AbbVie’s Juvmo will be available in October as a standalone or add-on therapy for treating Parkinson’s motor symptoms.

Leqembi and Kisunla clear amyloid plaques and modestly slow early Alzheimer's. Here's how these drugs work, their risks, and ...

Dr. Nathaniel Chin explains why repeat cognitive testing can reveal meaningful changes over time that a single score may miss ...

The symptoms of FTD overlap with many other psychiatric and neurological conditions like depression, bipolar disorder, borderline personality, and Parkinson’s disease. Since the symptoms start young, ...

Subscribe to get the latest and most trusted brain health science and news, straight to your inbox.

We welcome contributions from dementia and Alzheimer’s caregivers and from people who have or had a loved one with dementia. Think you might have a story to share? Please email [email protected] we ...

Sean Terwilliger spent four years trying to get a cognitive test. He discusses his early-onset Alzheimer's diagnosis, 18 months on Leqembi, and how writing helped him find purpose after his diagnosis.

October 16, 2026 @ 11:00 am - 11:30 am PDT ...

Many people think of virtual and augmented reality as popular forms of entertainment — but these technologies are becoming more central to healthcare, including neurological care. Virtual and ...

For vascular dementia, the second most common dementia, doctors rely on blood and cognitive tests, and brain scans to make a diagnosis and guide treatment. Vascular dementia leaves its mark on the ...

From movement and meals to sleep, social connection, and stress reduction, research shows small, consistent habits can support long-term cognitive health. As another year begins, many people reset ...

Would you still participate in an Alzheimer’s clinical trial if you found out that because of your genetics, you were more vulnerable to serious side effects? Homozygotes for the ApoE4 gene (people ...